National Association of Testing Authorities, Australia
Scope of Accreditation
NSW Health Pathology
Site
NSW Health Pathology St George Hospital Laboratory
Accreditation No.
2206
Site No.
2568
Date of Accreditation
08 Mar 1989
Address
Clinical Services Building, 30 Gray Street
Kogarah, NSW 2217
Australia
Contact
Mrs Ivy Fong P: +61 (02) 93823202
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Ambulatory Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Anatomical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Other body fluids; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue; Tissue imprint | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Fixed cytological smears; Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 2 mortuary |
| Anatomical pathology - Tissue pathology - Non-coronial autopsy services | Body; Body parts | Autopsy service and reporting |
Anticoagulant Clinic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Cardiac Catheter Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
CDS Resource Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Antibiotic susceptibility |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Isolates | Yeast susceptibility |
Chemistry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Ethanol |
| Urine | Amphetamines; Barbiturates; Benzodiazepines; Cannabis; Cocaine; Opiates | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Carbamazepine; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Paracetamol (acetaminophen); Phenobarbitone; Phenytoin (dilantin); Salicylate; Theophylline; Vancomycin |
| Digoxin | ||
| Paracetamol (acetaminophen); Valproate (valproic acid, epilim); Vancomycin | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Human chorionic gonadotropin (hCG); Prostate specific antigen (PSA); Prostate specific antigen (PSA) - Free; α-Fetoprotein (AFP) |
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Parathyroid hormone (PTH) |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Creatine kinase MB (CKMB) |
| Serum | Troponin T | |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum; Urine | Urate; Uric acid |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid; Drainage fluid; Pleural fluid | Amylase; Chloride; Lactate dehydrogenase (LDH); Lipase; Potassium; Sodium |
| Cerebrospinal fluid (CSF) | Glucose; Lactate dehydrogenase (LDH); Protein - Total | |
| Faeces; Serum; Urine | Osmolality | |
| Plasma | Ammonia | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; C-reactive protein (CRP); Calcium - Total; Carbon dioxide (CO2); Chloride; Cholesterol - LDL; Cholesterol - Total; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; γ-Glutamyltransferase | |
| Bilirubin - Any fractions; Bilirubin - Total; Creatine kinase | ||
| Urine | Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Plasma; Serum | Folate |
| Chemical pathology - Iron studies | Plasma; Serum | Iron; Transferrin |
| Serum | Ferritin | |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Reduced haemoglobin; Sodium |
| Pleural fluid | pH | |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Delivery suite
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); pH |
Diabetes Education Centre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Reduced haemoglobin; Sodium; pH |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Bone marrow | Heinz bodies; Iron | |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Presence of foetal red blood cells |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes |
| Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet aggregation |
| International normalised ratio (INR) | ||
| Platelet function (PFA) | ||
| Plasma | Activated partial thromboplastin time (APTT); Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Fondaparinux; Anti-Xa - Orgaran; Anti-Xa - Rivaroxaban; Anti-Xa activity; Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-Xa activity - Unfractionated heparin; D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT); Thrombin time (TT) | |
| Factor XIII | ||
| Activated protein C (APC) resistance; Anti-Xa - Dabigatran; Circulating coagulation factor inhibitors; Danaparoid sodium; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Lupus anticoagulant | ||
| Platelet factor 3 (PF3) availability | ||
| Serum | Heparin induced thrombotic thrombocytopenia (HITT) | |
| Immunoglobulin G (IgG) platelet surface antibodies; Platelet specific antibodies | ||
| Haematology - Investigation of haemolysis | Blood | Paroxysmal nocturnal haemoglobinuria (PNH) screen |
| Urine | Haemosiderin | |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | CD25 |
| CD25 | ||
| CD34 | ||
| CD34 | ||
| Blood; Bone marrow; Fresh tissue | CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD157; CD16; CD19; CD1a; CD2; CD20; CD200; CD22; CD23; CD235a; CD24; CD25; CD27; CD3; CD30; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD57; CD59; CD61; CD64; CD7; CD71; CD79a; CD79b; CD8; FMC7; Fluorescein-labelled proaerolysin (FLAER); HLA-DR antigen; Immunoglobulin M (IgM); Kappa light chains; Lambda light chains; Leukaemia screen; MPO; Myeloma screen; Natural killer (NK) cells; Paroxysmal nocturnal haemoglobinuria (PNH) surface markers; T-cell receptor aβ (TCRab); T-cell receptor γδ (TCRgd); Terminal deoxynucleotidyl transferase (TdT) | |
| CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD157; CD16; CD19; CD1a; CD2; CD20; CD200; CD22; CD23; CD235a; CD24; CD25; CD27; CD3; CD30; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD57; CD59; CD61; CD64; CD7; CD71; CD79a; CD79b; CD8; FMC7; Fluorescein-labelled proaerolysin (FLAER); HLA-DR antigen; Immunoglobulin M (IgM); Kappa light chains; Lambda light chains; Leukaemia screen; MPO; Myeloma screen; Natural killer (NK) cells; Paroxysmal nocturnal haemoglobinuria (PNH) surface markers; T-cell receptor aβ (TCRab); T-cell receptor γδ (TCRgd); Terminal deoxynucleotidyl transferase (TdT) | ||
| Fresh tissue | Viable cell count | |
| Viable cell count | ||
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells | Haemopoietic progenitor cells | Enumeration of CD34+ cells; Total leucocyte number |
| Enumeration of CD34+ cells; Total leucocyte number | ||
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Reduced haemoglobin; Sodium; pH |
Microbiology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Urine | Antigenic detection |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Bronchial washings | Mycobacterium tuberculosis |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Enrichment broth | Mycobacteria identification |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Ear swabs; Eye swabs; Fluids; General swabs; Genital swabs; Nasal swabs; Superficial sites; Throat swabs; Tissues; Urine; Wound swabs | Streptococcus group B screening; Bacteria; Crystals; Pathogenic microorganisms |
| Bacterial isolates | Pathogenic identification and antibiotic susceptibility | |
| Pathogenic identification and antibiotic susceptibility | ||
| Pathogenic identification and antibiotic susceptibility | ||
| Blood | Bacteria; Pathogenic microorganisms | |
| Bacteria; Pathogenic microorganisms | ||
| Fluids; Urine | Antigenic detection | |
| Urine | Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Axilla swabs; Nasal swabs; Rectal swabs | Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) |
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Blood transfusion bags; Environmental swabs; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | MecA gene; Nuc gene; Vancomycin resistant Enterococci (VRE) |
| Bacterial isolates; Blood; Cerebrospinal fluid (CSF) | Neisseria meningitidis | |
| Blood; Cerebrospinal fluid (CSF) | Listeria monocytogenes | |
| Blood; Cerebrospinal fluid (CSF); Pleural fluid | Streptococcus pneumoniae | |
| Bronchoalveolar lavage; Sputum | Legionella longbeachae; Legionella pneumophila | |
| Respiratory specimens | Bordetella pertussis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Blood; Cerebrospinal fluid (CSF) | Cryptococcus gattii; Cryptococcus neoformans |
| Skin scrapings | Dermatophyte identification | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Sputum | Mycobacterium tuberculosis |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal aspirate; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Blood; Body fluids; Broths; Cerebrospinal fluid (CSF); Cultures; Fluids; Isolates; Sputum | DNA storage for future analyses; Viable DNA; Viable DNA for sequencing |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Other body fluids; Respiratory specimens; Sputum | Mycobacteria identification |
| Mycobacteria identification | ||
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Blood; Skin scrapings; Tissues | Fungi identification; Yeasts identification |
Operating Theatres
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Chloride; Glucose; Haemoglobin (Hb); Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Quick Response Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Radiology Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Respiratory ward
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Chloride; Glucose; Haemoglobin (Hb); Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Special Care Nursery
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Reduced haemoglobin; Sodium; pH |
Transfusion
ISO 15189 (2022)
Human Pathology
Medicare expiry date
17 Feb 2027
Last Activity Date
06 Jun 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Investigation of haemolysis | Blood | Cold agglutinins |
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood; Plasma | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood; Plasma | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Red blood cell phenotyping |
| Antibody elution | ||
| Blood; Plasma | Other blood group antibodies; Rh | |
| Cord blood | Direct antiglobulin test (DAT, direct Coombs test) | |
| Plasma; Serum | Antibody titration | |
| Immunohaematology - Investigation of blood transfusion reactions | Blood; Blood products | Antibodies; Contamination - Microbiological; Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2206
Site No.
2568
Print date
15 Jan 2025
END OF SCOPE